RxDoctor Payments DataLook up a doctor →

Anne Chang, MD

Dermatology · Stanford, CANPI 1013049188

Payments from drug & device makers

$2,124,961in general payments, 2019–2025

Across 339 payments — averaging $6268.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$1.1M
  • Merck$977K
  • Galderma Laboratories, L.p.$42K
  • Sun Pharmaceutical Industries Inc.$21K
  • AbbVie$5K
  • Regeneron Healthcare Solutions, Inc.$3K
  • plus $828 from 4 others
$24,764in research payments, 2019–2025

Across 206 payments — averaging $120.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$23K
  • F. Hoffmann-la Roche AG$1K

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,124,961 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$113,145
Medicare patients
224
Services billed
2,465

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →